189 related articles for article (PubMed ID: 8857590)
1. Promotion of cell growth by stimulation of cloned human 5-HT1D receptor sites in transfected C6-glial cells is highly sensitive to intrinsic activity at 5-HT1D receptors.
Pauwels PJ; Wurch T; Palmier C; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):136-44. PubMed ID: 8857590
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors.
Pauwels PJ; Palmier C; Wurch T; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):144-56. PubMed ID: 8717154
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of cloned human serotonin 5-HT1D beta receptor sites in stably transfected C6 glial cells promotes cell growth.
Pauwels PJ; Wurch T; Amoureux MC; Palmier C; Colpaert FC
J Neurochem; 1996 Jan; 66(1):65-73. PubMed ID: 8522991
[TBL] [Abstract][Full Text] [Related]
4. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between partial and silent 5-HT1D beta receptor antagonists using rat C6-glial and Chinese hamster ovary cell lines permanently transfected with a cloned human 5-HT1D beta receptor gene.
Pauwels PJ; Colpaert FC
Biochem Pharmacol; 1995 Nov; 50(10):1651-8. PubMed ID: 7503768
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
Pauwels PJ; Wurch T; Palmier C; Colpaert FC
Br J Pharmacol; 1998 Jan; 123(1):51-62. PubMed ID: 9484854
[TBL] [Abstract][Full Text] [Related]
7. Selective antagonism of human 5-HT1D and 5-HT1B receptor-mediated responses in stably transfected C6-glial cells by ketanserin and GR 127,935.
Pauwels PJ; Colpaert FC
Eur J Pharmacol; 1996 Apr; 300(1-2):141-5. PubMed ID: 8741180
[TBL] [Abstract][Full Text] [Related]
8. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
[TBL] [Abstract][Full Text] [Related]
10. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord.
Manuel NA; Wallis DI; Crick H
Br J Pharmacol; 1995 Nov; 116(6):2647-54. PubMed ID: 8590984
[TBL] [Abstract][Full Text] [Related]
11. The activity of 5-HT1D receptor ligands at cloned human 5-HT1D alpha and 5-HT1D beta receptors.
Walsh DM; Beattie DT; Connor HE
Eur J Pharmacol; 1995 Dec; 287(1):79-84. PubMed ID: 8666030
[TBL] [Abstract][Full Text] [Related]
12. Functional effects of the 5-HT1D receptor antagonist GR 127,935 at human 5-HT1D alpha, 5-HT1D beta, 5-HT1A and opossum 5-HT1B receptors.
Pauwels PJ; Palmier C
Eur J Pharmacol; 1995 Jul; 290(2):95-103. PubMed ID: 8575538
[TBL] [Abstract][Full Text] [Related]
13. Stereoselectivity of 8-OH-DPAT enantiomers at cloned human 5-HT1D receptor sites.
Pauwels PJ; Colpaert FC
Eur J Pharmacol; 1996 Apr; 300(1-2):137-9. PubMed ID: 8741179
[TBL] [Abstract][Full Text] [Related]
14. Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.
Perren MJ; Feniuk W; Humphrey PP
Br J Pharmacol; 1991 Jan; 102(1):191-7. PubMed ID: 1675143
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
16. Activation of recombinant h 5-HT1B and h 5-HT1D receptors stably expressed in C6 glioma cells produces increases in Ca2+-dependent K+ current.
Le Grand B; Panissié A; Pauwels PJ; John GW
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):608-15. PubMed ID: 9879718
[TBL] [Abstract][Full Text] [Related]
17. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
18. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
19. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
Bühlen M; Fink K; Böing C; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
[TBL] [Abstract][Full Text] [Related]
20. Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro.
Maura G; Raiteri M
J Neurochem; 1996 Jan; 66(1):203-9. PubMed ID: 8522955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
